Live feed08:00:00·193dPRReleasevia QuantisnowNuCana Presents Encouraging Data on NUC-7738 in Combination with PD-1 Inhibitors using Primary Patient-Derived Organoids and Autologous Tumor-Infiltrating Lymphocytes at the ESMO Congress 2025ByQuantisnow·Wall Street's wire, on your screen.NCNA· NuCana plcHealth Care
